843 / 1138
α/β of prostate cancer
MIRALBELL IJROBP 2012
Pros:
N= 5969
No brachytherapy studies included
Cons:
Endpoint for α/β modelling: bRFS
Mix between 2D-RT, 3D-CRT, IMRT
SBRT for prostate cancer
ESTRO SBRT Course 2014 - Emerging SBRT indications
18